Loading data for SXTC — first visit, this takes a few seconds.
China SXT Pharmaceuticals, Inc. (SXTC)
NasdaqCM: SXTC
· Real-Time Price · USD
2.64
+0.08 (3.13%)
At close: Sep 01, 2026, 4:19 PM
The price, the headline numbers and the latest news, in one place.
China SXT Pharmaceuticals, Inc. (SXTC) Stock Price, Analysis & Data
No data available
| Bid | 4.29 |
| Market Cap | 1.41M |
| Revenue (ttm) | 1.14M |
| Net Income (ttm) | -6.21M |
| 1.89 | |
| -730.4 | |
| n/a | |
| n/a | |
| P/B (ttm) | 0.09 |
| P/S (ttm) | 1.24 |
| Earnings Date | n/a |
| Ask | 0.09 |
| Volume | 102,824 |
| Avg. Volume (20D) | 1,031,994 |
| Open | 2.55 |
| Previous Close | 2.56 |
| Day's Range | 2.55 - 2.91 |
| 52-Week Range | 2.55 - 83760.00 |
| Analyst | n/a |
| Price Target | n/a |
| Dividends | n/a |
| Ex-Dividend Date | n/a |
About SXTC
China SXT Pharmaceuticals, Inc., a pharmaceutical company, engages in the research, development, manufacture, marketing, and sale of traditional Chinese medicine pieces (TCMP) in China. The company offers Advanced TCMP, including Directly-Oral-TCMP, and After-Soaking-Oral TCMP; Fine TCMP and Regular TCMP products; and raw medicinal material, such as SanQiFen, HongQi, SuMu, JiangXiang, CuYanHuSuo, XiaTianWu, LuXueJing, XueJie, ChaoSuanZaoRen, Hong...
Sector Healthcare
IPO Date Jan 4, 2019
Employees 56
Stock Exchange NasdaqCM
Ticker Symbol SXTC
Website https://www.sxtchina.com
Financial Performance
In 2026, China SXT Pharmaceuticals's revenue was 1.14M, a decrease of -34.63% compared to the previous year's 1.74M. Earnings were -6.21M, an increase of 87.83%.
Financial StatementsEarnings Surprise
China SXT Pharmaceuticals has released their quarterly earnings on Invalid Date:
- Revenue of n/a misses estimates by $0, with NaN% YoY growth.
- EPS of misses estimates by , with NaN% YoY growth.
7 months ago · Associated Press Finance
BC-Most Active StocksElong Power Holding Ltd. 31,796,929 2.31